[Congressional Record (Bound Edition), Volume 151 (2005), Part 4]
[Senate]
[Page 5889]
[From the U.S. Government Publishing Office, www.gpo.gov]




       RECOGNIZING THE 50TH ANNIVERSARY OF THE SALK POLIO VACCINE

  Mr. ENZI. Mr. President, I ask unanimous consent the Senate now 
proceed to the consideration of S. Res. 101, which was submitted 
earlier today.
  The PRESIDING OFFICER. The clerk will report the resolution by title.
  The legislative clerk read as follows:

       A resolution (S. Res. 101) recognizing the 50th anniversary 
     of the development of the Salk polio vaccine and its 
     importance in eradicating the incidence of polio.

  There being no objection, the Senate proceeded to consider the 
resolution.
  Mr. ENZI. I ask unanimous consent that resolution be agreed to, the 
preamble be agreed to, and the motion to reconsider be laid upon the 
table.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The resolution (S. Res. 101) was agreed to.
  The preamble was agreed to.
  The resolution, with its preamble, is as follows:

                              S. Res. 101

       Whereas the epidemic of polio struck the citizens of the 
     United States in the early 1950s, causing thousands of cases 
     of lingering paralysis and death;
       Whereas the epidemic of polio peaked in 1952, having 
     affected nearly 58,000 people, mainly children and young 
     adults;
       Whereas many of those affected by polio needed the 
     assistance of mechanical ventilators in order to breathe, 
     while others were crippled and dependent upon crutches for 
     mobility;
       Whereas University of Pittsburgh faculty member Dr. Jonas 
     Salk and his team of researchers developed the first vaccine 
     against polio;
       Whereas, in April 1955, the results of an unprecedented and 
     successful nationwide clinical trial of the polio vaccine 
     were announced;
       Whereas the Salk polio vaccine was approved for widespread 
     public use at that time; and
       Now, therefore, be it
       Resolved, That the Senate--
       (1) recognizes the pioneering achievement of Dr. Jonas Salk 
     and his team of researchers at the University of Pittsburgh 
     in the development of the Salk polio vaccine;
       (2) expresses its appreciation to--
       (A) the family of Dr. Salk for the elimination of polio, a 
     disease that caused countless deaths and disabling 
     consequences;
       (B) the members of Dr. Salk's research team; and
       (C) the individuals who generously agreed to participate in 
     clinical trials to validate the efficacy of the polio 
     vaccine; and
       (3) celebrates with the University of Pittsburgh on the 
     50th anniversary of the approval and use of the Salk polio 
     vaccine.

                          ____________________